Skip to main content
. 2020 Apr 2;43(7):484–490. doi: 10.1097/COC.0000000000000691

FIGURE 2.

FIGURE 2

Period of stable disease observed in DLT evaluable patients administered SLC-0111. Each bar represents 1 patient and the period is measured as the number of 28 day cycles during which each patient maintained stable disease. DLT indicates dose-limiting toxicities.